Soluble Therapeutics Acquires Dilyx Biotechnologies
SynVivo-Tumor offers real-time analysis and visualization of drug delivery and cellular interactions and was showcased at the December ASCB meeting in San Francisco.
We are pleased to announce that current director Dr. Michael Chambers, JD, Ph.D., has been named Chairman of its Board of Directors. Dr. Chambers assumes the Chairmanship role from Rick Carlson, ProUroCare’s CEO, who will continue to serve as CEO and Director.